Easton Pharma starts talks with Israeli firm over possible deal; shares ahead 5%

|About: Easton Pharmaceuticals... (EAPH)|By:, SA News Editor

Thinly traded nano cap Eaton Pharmaceuticals (OTCPK:EAPH +5.1%) says it has signed a non-disclosure agreement with Israel-based agricultural products developer ahead of negotiations over deal with the company. Potential transactions include an acquisition, joint venture or a distribution agreement.

The Israeli firm produces crop protection products that are based on extracts from local plants in the Judean Desert.